Cadence Drops Plans for Topical Anti-Infective Drug
Thursday, March 12, 2009
Cadence Pharmaceuticals said March 12 it was ending plans to develop its topical anti-infective gel Omigard after the drug failed to meet its goals in a late-stage study...
Take 1 minute to subscribe and you'll get this story immediately, plus:
Already a subscriber? Sign in
- 52 weekly issues
- Subscriber-only digital content every business day, plus full access to SDBJ.com archives
- Book of Lists — the most comprehensive business resource in San Diego
- San Diego 500 — influential business leaders you need to know